Hong Kong Pharma Digital Technology Holdings Ltd.(HKPD)
$1.33-0.19 (-12.73%)
HKPD
Hong Kong Pharma Digital Technology Holdings Ltd. financials statements
$1.33
At close:-0.19 (-12.73%)
Hong Kong Pharma Digital Technology Holdings Ltd. (HKPD) Ratios
24 Followers
Hong Kong Pharma Digital Technology Holdings Ltd. Ratios
HKPD's free cash flow for Q4 2026 was $-507.62K. For the 2026 fiscal year, HKPD's free cash flow was decreased by $-37.00 and operating cash flow was $-507.58K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 3.86 | 2.99 | 2.46 | 1.08 |
| Quick Ratio | 3.75 | 2.80 | 2.16 | 1.00 |
| Cash Ratio | 0.07 | 0.26 | 0.20 | 0.21 |
| Solvency Ratio | -0.14 | 0.24 | 0.51 | 0.61 |
| Operating Cash Flow Ratio | -0.24 | 0.20 | -0.12 | 0.68 |
| Short-Term Operating Cash Flow Coverage | -0.86 | 1.53 | -1.83 | 27.70 |
| Net Current Asset Value | $ 9.07M | $ 4.30M | $ 3.39M | $ -73.05K |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.10 | 0.25 | 0.24 | 0.20 |
| Debt-to-Equity Ratio | 0.13 | 0.48 | 0.49 | 1.18 |
| Debt-to-Capital Ratio | 0.12 | 0.32 | 0.33 | 0.54 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.23 | 0.21 | 0.17 |
| Financial Leverage Ratio | 1.34 | 1.89 | 2.04 | 5.82 |
| Debt Service Coverage Ratio | -0.32 | 2.44 | 7.85 | 20.28 |
| Interest Coverage Ratio | -7.46 | 1.35 | 19.43 | 44.91 |
| Debt to Market Cap | 0.07 | 0.19 | 0.06 | 0.01 |
| Interest Debt Per Share | 1.18 | 0.27 | 0.29 | 0.06 |
| Net Debt to EBITDA | -3.26 | 1.35 | 0.58 | 0.09 |
| Profitability Margins | ||||
| Gross Profit Margin | 10.32% | 11.89% | 21.32% | 21.81% |
| EBIT Margin | -7.48% | 0.66% | 9.64% | 8.31% |
| EBITDA Margin | -2.37% | 5.94% | 15.19% | 14.01% |
| Operating Profit Margin | -7.41% | 0.65% | 9.64% | 8.31% |
| Pretax Profit Margin | -8.40% | 0.18% | 9.14% | 8.13% |
| Net Profit Margin | -8.46% | -0.13% | 7.97% | 7.95% |
| Continuous Operations Profit Margin | -8.46% | -0.13% | 7.97% | 7.95% |
| Net Income Per EBT | 100.68% | -74.92% | 87.14% | 97.79% |
| EBT Per EBIT | 113.41% | 27.35% | 94.88% | 97.79% |
| Return on Assets (ROA) | -8.84% | -0.29% | 15.34% | 29.30% |
| Return on Equity (ROE) | -11.85% | -0.54% | 31.26% | 170.56% |
| Return on Capital Employed (ROCE) | -10.31% | 2.03% | 29.29% | 121.84% |
| Return on Invested Capital (ROIC) | -9.18% | -1.34% | 22.10% | 79.97% |
| Return on Tangible Assets | -8.90% | -0.29% | 15.40% | 29.34% |
| Earnings Yield | -8.50% | -0.28% | 6.40% | 3.22% |
| Efficiency Ratios | ||||
| Receivables Turnover | 3.54 | 4.31 | 4.49 | 7.40 |
| Payables Turnover | 7.83 | 10.36 | 9.92 | 7.01 |
| Inventory Turnover | 33.45 | 31.96 | 14.07 | 51.43 |
| Fixed Asset Turnover | 30.94 | 34.21 | 20.02 | 19.19 |
| Asset Turnover | 1.05 | 2.16 | 1.93 | 3.69 |
| Working Capital Turnover Ratio | 1.80 | 3.89 | 6.92 | 0.00 |
| Cash Conversion Cycle | 67.42 | 60.87 | 70.50 | 4.38 |
| Days of Sales Outstanding | 103.15 | 84.69 | 81.33 | 49.35 |
| Days of Inventory Outstanding | 10.91 | 11.42 | 25.95 | 7.10 |
| Days of Payables Outstanding | 46.64 | 35.23 | 36.78 | 52.08 |
| Operating Cycle | 114.06 | 96.11 | 107.28 | 56.45 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -0.64 | 0.06 | -0.05 | 0.16 |
| Free Cash Flow Per Share | -0.67 | 0.05 | -0.07 | 0.15 |
| Dividend Paid and CapEx Coverage Ratio | -21.19 | 3.67 | -4.48 | 14.67 |
| Capital Expenditure Coverage Ratio | -21.19 | 3.67 | -4.48 | 14.67 |
| Operating Cash Flow Coverage Ratio | -0.60 | 0.24 | -0.19 | 2.50 |
| Operating Cash Flow to Sales Ratio | -0.06 | 0.03 | -0.02 | 0.14 |
| Free Cash Flow Yield | -5.89% | 4.25% | -2.32% | 5.19% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -11.72 | -400.00 | 15.62 | 31.08 |
| Price-to-Sales (P/S) Ratio | 0.99 | 0.48 | 1.24 | 2.47 |
| Price-to-Book (P/B) Ratio | 1.39 | 1.95 | 4.88 | 53.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -16.97 | 23.52 | -43.06 | 19.27 |
| Price-to-Operating Cash Flow Ratio | -17.78 | 17.12 | -52.67 | 17.96 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 3.94 | 0.16 | 0.00 |
| Enterprise Value Multiple | -45.30 | 9.42 | 8.77 | 17.73 |
| Enterprise Value | 14.40M | 11.37M | 22.24M | 31.19M |
| EV to EBITDA | -45.30 | 9.42 | 8.77 | 17.73 |
| EV to Sales | 1.07 | 0.56 | 1.33 | 2.48 |
| EV to Free Cash Flow | -18.29 | 27.45 | -46.10 | 19.38 |
| EV to Operating Cash Flow | -19.15 | 19.97 | -56.39 | 18.06 |
| Tangible Book Value Per Share | 8.09 | 0.54 | 0.57 | 0.05 |
| Shareholders’ Equity Per Share | 8.16 | 0.55 | 0.58 | 0.05 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | -0.01 | 1.75 | 0.13 | 0.02 |
| Revenue Per Share | 11.43 | 2.25 | 2.27 | 1.14 |
| Net Income Per Share | -0.97 | -0.00 | 0.18 | 0.09 |
| Tax Burden | 1.01 | -0.75 | 0.87 | 0.98 |
| Interest Burden | 1.12 | 0.27 | 0.95 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.18 | 0.11 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.66 | -21.04 | -0.30 | 1.73 |
Currency in USD

